[Experimental infection system in the inflammatory pouch of rats and the effect of cephalosporins].
D000818:Animals; D002509:Cephaloridine / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use; D004926:Escherichia coli / Q000254:growth & development; D004927:Escherichia coli Infections / Q000188:drug therapy*; D008297:Male; D009077:Mucins; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000254:growth & development; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use
D002511:Cephalosporins; D009077:Mucins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D002509:Cephaloridine; D002512:Cephalothin